Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Tianjin Medical University Cancer Institute and Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ningbo Liu, Doctor

Tianjin Medical University Cancer Institute and Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

SCLC, Extensive Stage

Worked with same sponsors:

Tianjin Medical University Cancer Institute and Hospital
Similarity Score30%

Dong Wang, PH.D

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

SCLC, Extensive Stage
Similarity Score30%

Shun Lu, Professor

Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiaotong University, P. R. China

Moderately Similar
1 trials

Shared therapeutic areas:

SCLC, Extensive Stage
Similarity Score30%

Shuhang wang, PhD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Moderately Similar
2 trials

Shared therapeutic areas:

SCLC, Extensive Stage
Similarity Score30%

Zhijie Wang, MD, PhD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Moderately Similar
1 trials

Shared therapeutic areas:

SCLC, Extensive Stage
Similarity Score30%

Yanqiu Zhao, MS

Henan Tumor Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

SCLC, Extensive Stage
Similarity Score30%

Martin Reck, Prof. Dr.

LungenClinic Grosshansdorf

Moderately Similar
1 trials

Shared therapeutic areas:

SCLC, Extensive Stage
Similarity Score30%

Dingzhi Huang, Doctor

Tianjin Medical University Cancer Institute and Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

SCLC, Extensive Stage

Worked with same sponsors:

Tianjin Medical University Cancer Institute and Hospital
Similarity Score30%

Chunxia Su, Doctor

Shanghai Pulmonary Hospital, Shanghai, China

Moderately Similar
2 trials

Shared therapeutic areas:

SCLC, Extensive Stage
Similarity Score30%

Richard Greil, MD

AGMT gemeinnützige GmbH

Moderately Similar
3 trials

Shared therapeutic areas:

SCLC, Extensive Stage
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05507593Phase 1PrincipalInvestigator

Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer

SCLC, Extensive Stage
Unknown

All 1 trials loaded